Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth

The successful treatment of atopic eczema (AE) should result in the improvement of both physical symptoms and patient′s quality of life (QoL). This study was conducted using a sample of dermatologists throughout Germany. This is due to dermatologists being the main health care providers of AE.

[1]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[2]  Magnus Lindberg,et al.  Self-reported lifetime prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood: a population-based cross-sectional survey. , 2013, Acta dermato-venereologica.

[3]  M. Chan-yeung,et al.  Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  A. P. Caldeira,et al.  An international multicenter study on quality of life and family quality of life in children with atopic dermatitis. , 2013, Indian journal of dermatology, venereology and leprology.

[5]  M. Kaplan,et al.  T helper cell subsets in the development of atopic dermatitis. , 2012, Journal of drugs in dermatology : JDD.

[6]  H. Williams,et al.  Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting , 2012, Allergy.

[7]  A. Paller,et al.  Atopic dermatitis: epidemiology and pathogenesis update. , 2012, Seminars in cutaneous medicine and surgery.

[8]  J. Ring,et al.  Guidelines for treatment of atopic eczema (atopic dermatitis) Part II , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  C. Sant’Anna,et al.  Quality of life in children and teenagers with atopic dermatitis. , 2012, Anais brasileiros de dermatologia.

[10]  J. Ring,et al.  Guidelines for treatment of atopic eczema (atopic dermatitis) Part I , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  J. Schmitt,et al.  Versorgungsforschung am Beispiel Neurodermitis , 2011 .

[12]  J. Schmitt.  [Health services research the example of atopic dermatitis]. , 2011, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[13]  H. Williams,et al.  Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany , 2010, The British journal of dermatology.

[14]  J. Noble,et al.  Data integrity, reliability and fraud in medical research. , 2010, European journal of internal medicine.

[15]  K. Reich,et al.  Evaluation of Quality of Care and Guideline-Compliant Treatment in Psoriasis , 2009, Dermatology.

[16]  M. Augustin,et al.  The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases , 2009, Archives of Dermatological Research.

[17]  P. Schmid‐Grendelmeier,et al.  Neurodermitis S2‐Leitlinie , 2009 .

[18]  L. Eichenfield,et al.  Management of Atopic Dermatitis in the Pediatric Population , 2008, Pediatrics.

[19]  K. Reich,et al.  Quality of psoriasis care in Germany – results of the national study PsoHealth 2007 , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[20]  L. Doward,et al.  Quality of life of children with atopic dermatitis and their families , 2008, Current opinion in allergy and clinical immunology.

[21]  K. Reich,et al.  Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany , 2008, Dermatology.

[22]  I. Schaefer,et al.  Development and validation of a new instrument for the assessment of patient‐defined benefit in the treatment of acne , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[23]  M. Barbeau,et al.  Burden of Atopic dermatitis in Canada , 2006, International journal of dermatology.

[24]  M. Bullinger,et al.  [Assessment of quality of life in dermatology]. , 2004, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[25]  M. Augustin,et al.  Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. , 2004, European journal of dermatology : EJD.

[26]  M. Augustin,et al.  Validation and Clinical Results of the FLQA-d, a Quality of Life Questionnaire for Patients with Chronic Skin Disease , 2000, Dermatology and Psychosomatics / Dermatologie und Psychosomatik.

[27]  Robert Rosenthal,et al.  Computing Contrasts, Effect Sizes, and Counternulls on Other People's Published Data: General Procedures for Research Consumers , 1996 .

[28]  S J Zyzanski,et al.  Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. , 1996, The Journal of investigative dermatology.

[29]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.